Latest News

Journal Articles

Brain and neurologic

12 months of headlines: the most-read cancer news of 2017

Novel immunotherapy provides potential treatment for diffuse intrinsic pontine glioma

PARP-inhibitor olaparib shows promise for glioblastoma


News round-up: 11th European Breast Cancer Conference

Treasure trove of 110 genes linked to breast cancer discovered

Novel blood test could quickly predict breast cancer patient’s response to palbociclib


Genetic fingerprints of every bowel cancer cell and bowel tumor revealed in novel study

Key genes and regulatory networks involved in the initiation, progression and invasion of colorectal cancer

Small, daily dose of Viagra may reduce colorectal cancer risk


Born to be bad: researchers identify the genetic roots of ‘killer' kidney cancers

Cyramza® meets primary endpoint of overall survival in liver cancer study

Advancing treatment options for medullary thyroid cancer: an interview with Jonathan Wadsley


New blood test could detect eight types of cancer

Elevated expression of a pharmacologic Polycomb signature predicts poor prognosis in gastric and breast cancer

Study links NF1 mutations to GIST tumors, highlighting the need for genetic testing


Researchers uncover 80 potential ways of targeting prostate cancer

Novel strategy revealed for overcoming drug resistance in testicular cancer

Adjuvant chemotherapy and follow-up for recurrences in localized testicular cancer


FORWARD I: a Phase III study of mirvetuximab soravtansine versus chemotherapy in platinum-resistant ovarian cancer

Case report - Pembrolizumab in recurrent advanced cervical squamous carcinoma

Cervical cancer - top content round-up

Head and neck

New test could diagnose esophageal cancer 8 years before symptoms appear

Novel liquid biopsy shows promise for early retinoblastoma diagnosis

Head and neck cancer: is there a future for combination immunotherapy?


News round-up: Green light from NICE for NSCLC immunotherapy; Pan-Cancer Atlas data and 40 myeloma genes unearthed

The patient and clinician's perspective on the recent recommendation of ixazomib

What are the treatment options for myeloma? John Ellwood's story


KEYTRUDA® scores big again in NSCLC Phase III KEYNOTE-189 study

Exploring the CheckMate-227 study: an interview with Christiain Ottensmeier

AACR 2018: highlights and the biggest news headlines


Survival and glycemic control outcomes among patients with coexisting pancreatic cancer and diabetes mellitus

Smartphone app shows promise for pancreatic cancer detection

Will gemcitabine monotherapy be dethroned as the adjuvant chemotherapy in pancreatic adenocarcinoma?


Prostate cancer deaths are not prevented by one-off PSA screening

‘Breakthrough’ prostate cancer test could cut diagnosis time from weeks to days

Breakaway cancerous cells successfully mapped and tracked with metal detection

Rare tumors

Larotrectinib shows 93% response rate in pediatric cancer trial

Our top 5 articles on rare cancers - a note from the Editor

Gilteritinib receives orphan designation for AML


AACR 2018: highlights and the biggest news headlines

AACR 2018: Positive data announced for KEYTRUDA® in adjuvant melanoma

The Patient Perspective on… immunotherapy advancements